<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">134002</id>
  <title nil="true"/>
  <common-name>Pasireotide</common-name>
  <description>Pasireotide is an organic compound with the chemical formula C58H66N10O9. Pasireotide belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 1,047 g/mol, Pasireotide is a heavy molecule.

This compound acts as an inhibitor of four specific protein targets: Somatostatin receptor type 1 (SSTR1), Somatostatin receptor type 2 (SSTR2), Somatostatin receptor type 3 (SSTR3), and Somatostatin receptor type 5 (SSTR5). Regarding its recorded sources, Pasireotide is associated with electrical and electronic equipment antennas, as well as healthcare, pharmaceuticals, and veterinary products specifically related to hypothalamic hormones. The recorded routes of exposure for this substance include subcutaneous and intramuscular administration.</description>
  <cas>396091-73-9</cas>
  <pubchem-id>9941444</pubchem-id>
  <chemical-formula>C58H66N10O9</chemical-formula>
  <weight>1047.2</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-14T16:19:53Z</created-at>
  <updated-at type="dateTime">2026-08-22T19:38:48Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB06663</drugbank-id>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1</moldb-smiles>
  <moldb-formula>C58H66N10O9</moldb-formula>
  <moldb-inchi>InChI=1S/C58H66N10O9/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72)/t43-,46+,47+,48-,49+,50+,51+/m1/s1</moldb-inchi>
  <moldb-inchikey>VMZMNAABQBOLAK-DBILLSOUSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">1047.2062</moldb-average-mass>
  <moldb-mono-mass type="decimal">1046.50142376</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.67</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM129895</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(3S,6R,9S,12S,15S,19R,20aS)-9-(4-aminobutyl)-15-benzyl-12-{[4-(benzyloxy)phenyl]methyl}-6-[(1H-indol-3-yl)methyl]-1,4,7,10,13,16-hexaoxo-3-phenyl-icosahydropyrrolo[1,2-a]1,4,7,10,13,16-hexaazacyclooctadecan-19-yl N-(2-aminoethyl)carbamate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic acids and derivatives</superklass>
  <klass>Carboxylic acids and derivatives</klass>
  <subklass>Amino acids, peptides, and analogues</subklass>
  <paper-count type="integer">2757</paper-count>
  <sync-id>CED0005714</sync-id>
  <structure-inchikey>VMZMNAABQBOLAK-DBILLSOUSA-N</structure-inchikey>
  <structure-fingerprint>4001010800000000000800002101100000000000000000004000000000000000000000000040220208200001008000004000000000010000020002000000000000000000200000000010000000000000022001000080100000200001040000000000000031000008000000000000010000000030100000400000400000200100022000800280020800000200200000080001000800100000000000000000001800800008020000104040000080000000000000000088000000000000004000000000000040000000100000000000001000000400000000000000222800401000000000000008000000041000000010400004000000000000000000000000020</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAABNAAAAVAAAAIABBwBgAAAAAQIGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:49:22Z</structure-indexed-at>
</compound>
